Septerna (SEPN) Other financing activities (2024 - 2026)
Septerna's (SEPN) quarterly Other financing activities came in at $333000.0 in Q1 2026, up 404.55% year-on-year from $66000.0 in Q1 2025, and up 9.54% quarter-over-quarter from $304000.0 in Q4 2025.
Septerna (SEPN) Other financing activities (2024 - 2026) Analysis & Trends
Septerna's Other financing activities history runs 3 years deep, the most recent figure standing at $333000.0 for Q1 2026.
- On a quarterly basis, Other financing activities rose 404.55% year-over-year to $333000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 99.59% decrease from a year earlier, with the FY2025 full-year figure at $973000.0, down 99.68% from the prior year.
- Other financing activities improved to $333000.0 in Q1 2026 per SEPN's latest filing, from $304000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $302.8 million in Q4 2024 and bottomed at $1000.0 in Q1 2024.
- The 3-year median for Other financing activities is $264000.0 (2025), against an average of $33.8 million.
- Biggest YoY gain for Other financing activities was 6500.0% in 2025; the steepest drop was 99.9% in 2025.
- Year by year, Other financing activities stood at $302.8 million in 2024, then sank by 99.9% to $304000.0 in 2025, then climbed by 9.54% to $333000.0 in 2026.
- Per Business Quant, the three latest SEPN Other financing activities figures stand at $333000.0 (Q1 2026), $304000.0 (Q4 2025), and $264000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 333,000.00 |
| Mar 31, 2026 | 333,000.00 |
| Dec 31, 2025 | 304,000.00 |
| Dec 31, 2025 | 304,000.00 |
| Sep 30, 2025 | 264,000.00 |
| Sep 30, 2025 | 264,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 339,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 302.77 Mn |
| Dec 31, 2024 | 302.77 Mn |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |